The Insulin Pump Market was valued at USD 5.13 Billion in 2023 and is expected to reach USD 17.52 Billion By 2031 and grow at a CAGR of 16.6% over the forecast period of 2024-2031.
The term insulin pump market refers to the sector of the economy that is centred on the Disease Indicationion, marketing, and sale of insulin pumps. Diabetes patients utilise insulin pumps, which are medical equipment, to control their blood sugar levels. They deliver an ongoing supply of insulin, simulating the pancreas' normal function in those with type 1 and, in certain situations, type 2 diabetes. Insulin pumps are typically tiny, battery-powered gadgets that can be carried in a pocket or worn on a belt. They are made up of an insulin reservoir, a programmable pump system, and a catheter that administers insulin to the user's body via a thin tube or skin prick.
To Get More Information on Insulin Pump Market - Request Sample Report
The availability of cutting-edge, innovative pumps and their accessibility are the main factors propelling the growth of the worldwide insulin pump market. The market is growing as a result of market participants' growing investments in the research and development of drug delivery systems, which has sparked the creation of insulin pumps with a primary focus on patient comfort. The introduction of smart technologies like artificial intelligence in the healthcare sector is also hastening patient adoption of automated insulin pumps. The global market for insulin pumps is also growing as a result of the rising number of Disease Indication approvals and various market participants' use of developmental strategies like partnerships, distribution contracts, and collaborations.
Compared to conventional injection techniques, insulin pumps give diabetics more freedom in regulating their condition.
Increasing Diabetes Technology Adoption.
The market for insulin pumps has benefited from the growing use of diabetes care technology, including continuous glucose monitoring (CGM) systems. Better glucose control and a lower risk of hypo and hyperglycemia are made possible by the integration of insulin pumps with CGM devices.
Restrain
The initial investment cost of insulin pumps can be high, and for some people, this may be a barrier to their adoption.
Favour traditional injection techniques.
Despite the ease and glycemic control advantages of insulin pumps, some people may still favour older injection techniques due to personal preferences, aversion to technology, or ignorance of insulin pump therapy. To spread the word about the benefits of insulin pump therapy and dispel misunderstandings, patient education and awareness campaigns are essential.
Opportunity
Utilising the information produced by insulin pumps and other technology for managing diabetes can offer insightful information for individualised treatment recommendations and decision-making.
Personalization and customization.
Insulin pumps can accommodate users' unique requirements and preferences if they have customizable features like bolus calculators, adjustable basal rates, and personalised settings. Manufacturers can concentrate on creating insulin pumps with a high level of customization and modification to improve diabetes treatment for various individuals.
Challenge
Due to a number of circumstances, such as restricted accessibility in some areas, a lack of healthcare infrastructure, and discrepancies in healthcare access, insulin pump therapy may not be available to everyone.
Complexity of the Device and User Learning Curve.
In order to use insulin pumps effectively, one must have the appropriate training and information. Some people find the initial setup and learning curve difficult, which could result in mistakes or issues operating the device appropriately. To solve this problem, thorough patient education and continued assistance are essential.
The conflict between Ukraine and Russia is having a big effect on the economies of both nations and other nations. While deliveries to the Russian biotech and pharmaceutical industries are not currently impacted by sanctions as of the reporting date, this may change in the future. In spite of logistical difficulties, Ypsomed fulfils its duties and provides pharmaceutical firms with life-saving insulin pens. It is impossible to rule out future negative consequences for Ypsomed, such as those brought on by potential payment limits. Insulin pump market-based companies in Russia have halted marketing expenditures and shifted their attention away from clinical research and the introduction of new drugs to securing a supply of insulin to guarantee that their patients have access to these crucial medications. Only Russian patients in Russia receive insulin from their manufacturers there.
The exchange rates will stay the same, with the US dollar in particular. Additionally, the projection excludes any significant business growth deals and intangible asset losses that may occur in 2023 and their financial ramifications. Last but not least, the potential broader ramifications of Russia's invasion of Ukraine, including effects on the energy supply and supply chains, could create uncertainty in the outlook and the financial performance of the company situated in the Insulin Pump Market.
By Product Type
Patch Pumps
Tethered Pumps
Others
By Disease Indication
Type 2 Diabetes
By Distribution Channel
Hospital Pharmacy
Retail
North America
USA
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Rest of Europe
Asia-Pacific
Japan
South Korea
China
India
Australia
Rest of Asia-Pacific
The Middle East & Africa
Israel
UAE
South Africa
Rest of the Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
Regional Analysis
North America: The market for insulin pumps is widely established in North America, especially in the United States. Due to the high incidence of diabetes in the area and the region's robust healthcare system, insulin pump therapy is widely used. The market in this region is expanding as a result of technological developments, favourable reimbursement policies, and a proactive attitude towards diabetes control. North American companies like Tandem Diabetes Care and Medtronic are significant players in the insulin pump business.
Asia-Pacific: Because of its large population, rising diabetes prevalence, and expanding healthcare system, the Asia-Pacific area has enormous growth potential for the insulin pump industry. As knowledge of diabetes and access to healthcare increase, so has the demand for insulin pumps in nations like China, India, and Japan. In some areas of the region, affordability is still a problem, but there are initiatives to improve insurance options and make them more affordable. Both domestic and foreign businesses are actively pursuing the Asia-Pacific market.
Do You Need any Customization Research on Insulin Pump Market - Enquire Now
The major players are Hoffmann-La Roche Ltd., Insulet Corporation, Ypsomed, Cellnovo, Sooil Development, Valeritas, Inc., JingasuDelfu Co., Ltd., Medtronic plc, Tandem Diabetic Care, Inc., Microport Scientific and the final reports list additional participants.
Insulet Corporation: A leader in the development of tubeless insulin pump products and technologies said in 2022 that it would invest around USD $200 million over the ensuing five years in its intended production facility in Johor. By doing this, the business would be able to create its Omnipod Insulin Management System as part of its goal to improve its global manufacturing capabilities.
Ypsomed: A partnership between Ypsomed, Abbott, and CamDiab to create an integrated AID (automated insulin delivery) system was announced in 2022. Abbott's FreeStyle Libre 3 and Ypsomed's MyLife YpsoPump will be connected by the new integrated AID system to create a smart, automatic process for dispensing insulin with accurate glucose readings.
SOOIL Development: At the American Diabetes Association Scientific Sessions in 2022, Diabeloop, a global leader in therapeutic Al, and SOOIL Development Company, a pioneer in cutting-edge diabetes therapy, announced a deal for global development. Clinical studies are expected to be established as part of the partnership in order to increase their level of cooperation and give as many patients access to their goods as feasible through new, cutting-edge items.
| Report Attributes | Details |
| Market Size in 2023 | US$ 5.13 Bn |
| Market Size by 2031 | US$ 17.52 Bn |
| CAGR | CAGR of 16.4 % From 2024 to 2031 |
| Base Year | 2023 |
| Forecast Period | 2024-2031 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product Type (Patch Pumps, Tethered Pumps, and Others) • By Disease Indication (Type1 Diabetes and Type 2 Diabetes) • By Distribution Channel (Hospital Pharmacy, Retail & Online Pharmacy) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Hoffmann-La Roche Ltd., Insulet Corporation, Ypsomed, Cellnovo, Sooil Development, Valeritas, Inc., JingasuDelfu Co., Ltd. Medtronic plc, andem Diabetic Care, Inc. Microport Scientific |
| Key Drivers | • Compared to conventional injection techniques, insulin pumps give diabetics more freedom in regulating their condition. • Increasing Diabetes Technology Adoption. |
| Market Opportunities | • Utilising the information produced by insulin pumps and other technology for managing diabetes can offer insightful information for individualised treatment recommendations and decision-making. • Personalization and customization. |
Ans: The Insulin Pump Market size was valued at USD 4.40 Billion in 2022
Ans: The Insulin Pump Market is to grow at 16.4% Over the Forecast Period 2023-2030.
Ans: The Insulin Pump Market is to Hit USD 14.82 Billion by 2030.
Ans: Medtronic continues to dominate the market.
Ans: The major key players are Hoffmann-La Roche Ltd., Insulet Corporation, Ypsomed, Cellenovo, Sooil Development, Valeritas, Inc., JingasuDelfu Co., Ltd. Medtronic plc, andem Diabetic Care, Inc. Microport Scientific and others
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1Impact of the Ukraine-Russia War
4.1.1 Introduction
4.1.2 Impact on major economies
4.1.2.1 US
4.1.2.2 Canada
4.1.2.3 Germany
4.1.2.4 France
4.1.2.5 United Kingdom
4.1.2.6 China
4.1.2.7 Japan
4.1.2.8 South Korea
4.1.2.9 Rest of the World
4.1 Supply Demand Gap Analysis
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Global Human Insulin Market Segmentation, By Product Type
8.1 Patch Pumps
8.2 Tethered Pumps
8.3 Others
9. Insulin Pump Market Segmentation, By Disease Indication
9.1 Type1 Diabetes
9.2 Type 2 Diabetes
10. Insulin Pump Market Segmentation By Distribution Channel
10.1 Hospital Pharmacy
10.2 Retail
10.3 Online Pharmacy
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 North America Insulin Pump Market by Country
11.2.2North America Insulin Pump Market by Product Type
11.2.3 North America Insulin Pump Market by Disease Indication
11.2.4 North America Insulin Pump Market by Distribution Channel
11.2.5 USA
11.2.5.1 USA Insulin Pump Market by Product Type
11.2.5.2 USA Insulin Pump Market by Disease Indication
11.2.5.3 USA Insulin Pump Market by Distribution Channel
11.2.6 Canada
11.2.6.1 Canada Insulin Pump Market by Product Type
11.2.6.2 Canada Insulin Pump Market by Disease Indication
11.2.6.3 Canada Insulin Pump Market by Distribution Channel
11.2.7 Mexico
11.2.7.1 Mexico Insulin Pump Market by Product Type
11.2.7.2 Mexico Insulin Pump Market by Disease Indication
11.2.7.3 Mexico Insulin Pump Market by Distribution Channel
11.8 Europe
11.8.1 Europe Insulin Pump Market by Country
11.8.2 Europe Insulin Pump Market by Product Type
11.8.3 Europe Insulin Pump Market by Disease Indication
11.8.4 Europe Insulin Pump Market by Distribution Channel
11.8.6 Germany
11.8.6.1 Germany Insulin Pump Market by Product Type
11.8.6.2 Germany Insulin Pump Market by Disease Indication
11.8.6.3 Germany Insulin Pump Market by Distribution Channel
11.8.7 UK
11.8.7.1 UK Insulin Pump Market by Product Type
11.8.7.2 UK Insulin Pump Market by Disease Indication
11.8.7.3 UK Insulin Pump Market by Distribution Channel
11.8.8 France
11.8.8.1 France Insulin Pump Market by Product Type
11.8.8.2 France Insulin Pump Market by Disease Indication
11.8.8.3 France Insulin Pump Market by Distribution Channel
11.9.9 Italy
11.3.9.1 Italy Insulin Pump Market by Product Type
11.3.9.2 Italy Insulin Pump Market by Disease Indication
11.3.9.3 Italy Insulin Pump Market by Distribution Channel
11.3.10 Spain
11.3.10.1 Spain Insulin Pump Market by Product Type
11.3.10.2 Spain Insulin Pump Market by Disease Indication
11.3.10.3 Spain Insulin Pump Market by Distribution Channel
11.3.11 The Netherlands
11.3.11.1 Netherlands Insulin Pump Market by Product Type
11.3.11.2 Netherlands Insulin Pump Market by Disease Indication
11.3.11.3 Netherlands Insulin Pump Market by Distribution Channel
11.3.12 Rest of Europe
11.3.11.1 Rest of Europe Insulin Pump Market by Product Type
11.3.11.2 Rest of Europe Insulin Pump Market by Disease Indication
11.3.11.3 Rest of Europe Insulin Pump Market by Distribution Channel
11.4 Asia-Pacific
11.4.1 Asia Pacific Insulin Pump Market by Country
11.4.1 Asia Pacific Insulin Pump Market by Product Type
11.4.3 Asia Pacific Insulin Pump Market by Disease Indication
11.4.4Asia Pacific Insulin Pump Market by Distribution Channel
11.4.6 Japan
11.4.6.1 Japan Insulin Pump Market by Product Type
11.4.6.2 Japan Insulin Pump Market by Disease Indication
11.4.6.3 Japan Insulin Pump Market by Distribution Channel
11.4.7 South Korea
11.4.7.1 South Korea Insulin Pump Market by Product Type
11.4.7.2 South Korea Insulin Pump Market by Disease Indication
11.4.7.3 South Korea Insulin Pump Market by Distribution Channel
11.4.8 China
11.4.8.1 China Insulin Pump Market by Product Type
11.4.8.2 China Insulin Pump Market by Disease Indication
11.4.8.3 China Insulin Pump Market by Distribution Channel
11.4.9 India
11.4.9.1 India Insulin Pump Market by Product Type
11.4.9.2 India Insulin Pump Market by Disease Indication
11.4.9.3 India Insulin Pump Market by Distribution Channel
11.4.10 Australia
11.4.10.1 Australia Insulin Pump Market by Product Type
11.4.10.2 Australia Insulin Pump Market by Disease Indication
11.4.10.3 Australia Insulin Pump Market by Distribution Channel
11.4.11 Rest of Asia-Pacific
11.4.11.1 APAC Insulin Pump Market by Product Type
11.4.11.2 APAC Insulin Pump Market by Disease Indication
11.4.11.3 APAC Insulin Pump Market by Distribution Channel
11.5 The Middle East & Africa
11.5.1 The Middle East & Africa Insulin Pump Market by Country
11.5.2 The Middle East & Africa Insulin Pump Market by Product Type
11.5.3 The Middle East & Africa Insulin Pump Market by Disease Indication
11.5.4The Middle East & Africa Insulin Pump Market by Distribution Channel
11.5.6 Israel
11.5.6.1 Israel Insulin Pump Market by Product Type
11.5.6.2 Israel Insulin Pump Market by Distribution Channel
11.5.6.3 Israel Insulin Pump Market by Disease Indication
11.5.7 UAE
11.5.7.1 UAE Insulin Pump Market by Product Type
11.5.7.2 UAE Insulin Pump Market by Disease Indication
11.5.7.3 UAE Insulin Pump Market by Distribution Channel
11.5.8 South Africa
11.5.8.1 South Africa Insulin Pump Market by Product Type
11.5.8.2 South Africa Insulin Pump Market by Disease Indication
11.5.8.3 South Africa Insulin Pump Market by Distribution Channel
11.5.9 Rest of Middle East & Africa
11.5.9.1 Rest of Middle East & Asia Insulin Pump Market by Product Type
11.5.9.2 Rest of Middle East & Asia Insulin Pump Market by Disease Indication
11.5.9.3 Rest of Middle East & Asia Insulin Pump Market by Distribution Channel
11.6 Latin America
11.6.1 Latin America Insulin Pump Market by Country
11.6.2 Latin America Insulin Pump Market by Product Type
11.6.3 Latin America Insulin Pump Market by Disease Indication
11.6.4 Latin America Insulin Pump Market by Distribution Channel
11.6.6 Brazil11.6.6.1 Brazil Insulin Pump Market by Product Type
11.6.6.2 Brazil Africa Insulin Pump Market by Disease Indication
11.6.6.3Brazil Insulin Pump Market by Distribution Channel
11.6.7 Argentina
11.6.7.1 Argentina Insulin Pump Market by Product Type
11.6.7.2 Argentina Insulin Pump Market by Disease Indication
11.6.7.3 Argentina Insulin Pump Market by Distribution Channel
11.6.8 Rest of Latin America
11.6.8.1 Rest of Latin America Insulin Pump Market by Product Type
11.6.8.2 Rest of Latin America Insulin Pump Market by Disease Indication
11.6.8.3 Rest of Latin America Insulin Pump Market by Distribution Channel
12. Company profile
12.1 Hoffmann-La Roche Ltd
12.1.1 Market Overview
12.1.2 Financials
12.1.3 Products/Services/Offerings
12.1.4 SWOT Analysis
12.1.5 The SNS View
12.2 Insulet Corporation
12.2.1 Market Overview
12.2.2 Financials
12.2.3 Products/Services/Offerings
12.2.4 SWOT Analysis
12.2.5 The SNS View
12.3 Ypsomed
12.3.1 Market Overview
12.3.2 Financials
12.3.3 Products/Services/Offerings
12.3.4 SWOT Analysis
12.3.5 The SNS View
12.4 Cellnovo
12.4.1 Market Overview
12.4.1 Financials
12.4.3 Products/Services/Offerings
12.4.4 SWOT Analysis
12.4.5 The SNS View
12.5 Sooil Development
12.5.1 Market Overview
12.5.2 Financials
12.5.3 Products/Services/Offerings
12.5.4 SWOT Analysis
12.5.5 The SNS View
12.6 Valeritas, Inc
12.6.1 Market Overview
12.6.2 Financials
12.6.3 Products/Services/Offerings
12.6.4 SWOT Analysis
12.6.5 The SNS View
12.7 JingasuDelfu Co
12.7.1 Market Overview
12.7.2 Financials
12.7.3 Products/Services/Offerings
12.7.4 SWOT Analysis
12.7.5 The SNS View
12.8 Medtronic plc
12.8.2 Financials
12.8.3 Products/Services/Offerings
12.8.4 SWOT Analysis
12.8.5 The SNS View
12.9 andem Diabetic Care, Inc
12.9.1 Market Overview
12.9.2 Financials
12.9.3 Products/Services/Offerings
12.9.4 SWOT Analysis
12.9.5 The SNS View
12.10. Microport Scientific
12.10.1 Market Overview
12.10.2 Financials
12.10.3 Products/Services/Offerings
12.10.4 SWOT Analysis
12.10.5 The SNS View
13. Competitive Landscape
13.1 Competitive Benchmarking
13.2 Market Share analysis
13.3 Recent Developments
14. Use cases and Best Practices
15. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The DNA Synthesis Market size was estimated USD 2.9 billion in 2022 and is expected to reach USD 12.2 billion by 2030 at a CAGR of 19.7% during the forecast period of 2023-2030.
The Sleep Disorder Treatment Market size was valued at US$ 9.2 billion in 2022 and is projected to reach US$ 18 billion by 2030, with a growing CAGR of 8.7% over the forecast period 2023-2030.
The Healthcare Payer Services Market Size was valued at USD 62.67 billion in 2022 and is expected to reach USD 111.7 billion by 2030 and grow at a CAGR of 7.5% over the forecast period 2023-2030.
The Remote Patient Monitoring (RPM) Market Size was valued at USD 51.4 billion in 2022, and is expected to reach USD 354.49 billion by 2030, and grow at a CAGR of 27.3% over the forecast period 2023-2030.
The Bioremediation Market size was estimated USD 13.4 billion in 2022 and is expected to reach USD 28.3 billion by 2030 at a CAGR of 9.8% during the forecast period of 2023-2030.
The Real-Time PCR (qPCR) Market Size was valued at USD 5.2 billion in 2022 and expected to reach USD 8.07 billion by 2030, and grow at a CAGR of 5.65% over the forecast period 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
